Compare TNC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNC | DRTS |
|---|---|---|
| Founded | 1870 | 2015 |
| Country | United States | Israel |
| Employees | N/A | 121 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 978.2M |
| IPO Year | 1994 | N/A |
| Metric | TNC | DRTS |
|---|---|---|
| Price | $88.30 | $9.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $79.00 | $8.67 |
| AVG Volume (30 Days) | 138.7K | ★ 935.5K |
| Earning Date | 05-04-2026 | 05-18-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,137,600,000.00 | N/A |
| Revenue This Year | $5.77 | N/A |
| Revenue Next Year | $4.95 | $699.98 |
| P/E Ratio | $9,015.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.18 | $2.87 |
| 52 Week High | $91.64 | $11.62 |
| Indicator | TNC | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 53.48 |
| Support Level | $79.15 | $6.59 |
| Resistance Level | $88.53 | $11.48 |
| Average True Range (ATR) | 2.31 | 0.76 |
| MACD | 0.15 | -0.04 |
| Stochastic Oscillator | 61.50 | 45.74 |
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.